The Dangers of Race Based Medicine The Dangers of Race-Based Medicine An analysis of sweet do medicines therapies specifically tar lift backed towards African American populations with hypertension I. founding to Contemporary Race-Based Therapeutics On November 11th, 2004, NitroMed, a Massachusetts based pharmaceutic company published a study on the effectuate of a new drug called BiDil in treating heart chastisement among African Americans in the modernistic England Journal of Medicine (Taylor 2049). Since announcing the study, NitroMeds research has sparked controversy environ the ethical implications and scientific inference of race-based medicine.
This study marks a breakthrough in race-based drug treatments as the first pharmaceutic ever researched, endorsed and targeted for a single(a) ethnic group (Pollack 1). The racially-specific pharmaceutical enterprise is a harvest-feast of tremendous government funding allotted by the Clinton governing body to the Human Genome Project at the turn of the mill...If you want to get a full essay, order it on our website:
OrderCustomPaper.comIf you want to get a full essay, visit our page:
write my paper
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.